Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|March 20, 2013
Role of inositol phospholipid signaling in natural killer cell biologyMatthew Gumbleton, William G Kerr
Journal of Immunology (Baltimore, Md. : 1950)|February 18, 2015
SHIP1 intrinsically regulates NK cell signaling and education, resulting in tolerance of an MHC class I-mismatched bone marrow graft in miceMatthew Gumbleton, Eric Vivier, William G Kerr
Stem Cells and Development|December 20, 2014
SHIP1-expressing mesenchymal stem cells regulate hematopoietic stem cell homeostasis and lineage commitment during agingSonia Iyer, Robert Brooks, Matthew Gumbleton, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
HNF4α controls growth, identity and response to KRAS inhibition of invasive mucinous adenocarcinoma of the lungHeadtlove Essel Dadzie, Yangsook Song Green, Soledad Camolotto, et al.
Science Signaling|October 12, 2017
Dual enhancement of T and NK cell function by pulsatile inhibition of SHIP1 improves antitumor immunity and survivalMatthew Gumbleton, Raki Sudan, Sandra Fernandes, et al.
Ebiomedicine|June 9, 2015
SHIPi Enhances Autologous and Allogeneic Hematolymphoid Stem Cell TransplantationSandra Fernandes, Robert Brooks, Matthew Gumbleton, et al.
BMC Research Notes|February 16, 2023
A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)Matthew Gumbleton, Stephanie Allan, Hannah Conway, et al.
Molecular Medicine (Cambridge, Mass.)|October 29, 2011
Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancerGwenny M Fuhler, Robert Brooks, Bonnie Toms, et al.
The Journal of Clinical Investigation|May 12, 2026
HNF4α controls growth, identity, and KRAS inhibitor response in invasive mucinous adenocarcinoma of the lungHeadtlove Essel Dadzie, Yangsook Song Green, Soledad Camolotto, et al.
Clinical Lung Cancer|November 21, 2024
Augmenting Prognostication: Utilizing Activity Trackers to Enhance Survival Prediction in Metastatic Non-Small Cell Lung CancerYeonjung Jo, Sonam Puri, Benjamin Haaland, et al.
Pageof 2